Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 4/20 | 0.54 |
| ▸ | ACHE | P22303 | 1/20 | 0.54 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.50 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.50 |
| ▸ | CA1 | P00915 | 1/20 | 0.46 |
| ▸ | CA2 | P00918 | 1/20 | 0.46 |
| ▸ | MAPT | P10636 | 2/20 | 0.45 |
| ▸ | NOTUM | Q6P988 | 1/20 | 0.44 |
| ▸ | LDHA | P00338 | 2/20 | 0.43 |
| ▸ | LDHB | P07195 | 2/20 | 0.43 |
| ▸ | RXRB | P28702 | 3/20 | 0.41 |
| ▸ | RXRA | P19793 | 2/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.41 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.40 |
| ▸ | MEN1 | O00255 | 3/20 | 0.40 |
| ▸ | HPGD | P15428 | 2/20 | 0.40 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL4355572 | 0.97 | CYP3A4 (0.52) | CYP3A4ACHEALDH1A1MAPK1SMN1; SMN2 | |
| SCHEMBL17177741 | 0.97 | CYP3A4 (0.52) | CYP3A4ACHEALDH1A1MAPK1SMN1; SMN2 | |
| SCHEMBL6061524 | 0.91 | CA1 (0.64) | CYP3A4ACHEALDH1A1MAPK1SMN1; SMN2 | |
| SCHEMBL19435461 | 0.91 | RXRB (0.55) | CYP3A4ACHEALDH1A1MAPK1SMN1; SMN2 | |
| SCHEMBL2882724 | 0.89 | KDM4E (0.47) | CYP3A4ACHEALDH1A1SMN1; SMN2MAPT | |
| SCHEMBL4659030 | 0.85 | MCL1 (0.48) | CYP3A4ACHEALDH1A1MAPK1SMN1; SMN2 | |
| SCHEMBL377596 | 0.83 | KDM4E (0.55) | CYP3A4ACHEALDH1A1MAPK1SMN1; SMN2 | |
| SCHEMBL21870 | 0.83 | KDM4E (0.55) | CYP3A4ACHEALDH1A1MAPK1SMN1; SMN2 | |
| SCHEMBL3757424 | 0.83 | NAPRT (0.43) | CYP3A4ACHEALDH1A1MAPK1SMN1; SMN2 | |
| SCHEMBL4355570 | 0.81 | CA1 (0.43) | CYP3A4ACHEALDH1A1MAPK1SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 77 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113801336-B | Functionalization of metal organic framework material UiO-67-4Me, functionalized product and application thereof | 中山大学 | 2022-06-24 | — | — | CN | claimed |
| US-5342904-A | Polymer modified adducts of epoxy resins and active hydrogen containing compounds containing mesogenic moieties | THE DOW CHEMICAL COMPANY (US) | 1994-08-30 | — | — | US | claimed |
| US-5235008-A | Curable | THE DOW CHEMICAL COMPANY (US) | 1993-08-10 | — | — | US | claimed |
| CN-113801336-B | Functionalization of metal organic framework material UiO-67-4Me, functionalized product and application thereof | 中山大学 | 2022-06-24 | — | — | CN | disclosed |
| CN-113801336-A | Functionalization of metal organic framework material UiO-67-4Me, functionalized product and application thereof | 中山大学 | 2021-12-17 | — | — | CN | disclosed |
| US-10738068-B2 | Organic/inorganic hybrid nanoparticulates made from iron carboxylates | Centre National de la Recherche Scientifique—CNRS (FR) | 2020-08-11 | — | — | US | disclosed |
| US-10738068-B2 | Organic/inorganic hybrid nanoparticulates made from iron carboxylates | Centre National de la Recherche Scientifique—CNRS (FR) | 2020-08-11 | — | — | US | disclosed |
| US-20190211202-A1 | ADDUCTS AND USES THEREOF | HUNTSMAN ADVANCED MATERIALS AMERICAS LLC | 2019-07-11 | — | — | US | disclosed |
| EP-3500627-A1 | ADDUCTS AND USES THEREOF | Huntsman Advanced Materials Americas LLC (US) | 2019-06-26 | — | — | EP | disclosed |
| US-20180346500-A1 | ORGANIC/INORGANIC HYBRID NANOPARTICULATES MADE FROM IRON CARBOXYLATES | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) | 2018-12-06 | — | — | US | disclosed |
| EP-2726530-B1 | HYBRID EPOXY RESIN ADDUCTS | BLUE CUBE IP LLC (US) | 2018-09-12 | — | — | EP | disclosed |
| US-20040116619-A1 | Polyester resins with improved properties | POLYMERS AUSTRALIA PTY LIMITED (AU) | 2004-06-17 | — | — | US | disclosed |
| EP-1317497-A1 | POLYESTER RESINS WITH IMPROVED PROPERTIES | Polymers Australia PTY Limited (AU) | 2003-06-11 | — | — | EP | disclosed |
| WO-2002022705-A1 | POLYESTER RESINS WITH IMPROVED PROPERTIES | POLYMERS AUSTRALIA PTY LTD (AU) | 2002-03-21 | — | — | WO | disclosed |
| US-5602211-A | CURING AGENTS | THE DOW CHEMICAL COMPANY (US) | 1997-02-11 | — | — | US | disclosed |
| US-5414121-A | Adducts of epoxy resins and active hydrogen containing compounds containing mesogenic moieties | THE DOW CHEMICAL COMPANY (US) | 1995-05-09 | — | — | US | disclosed |
| US-5276184-A | Curing agents for epoxy resins for thermosetting resins | THE DOW CHEMICAL COMPANY (US) | 1994-01-04 | — | — | US | disclosed |
| US-5235008-A | Curable | THE DOW CHEMICAL COMPANY (US) | 1993-08-10 | — | — | US | disclosed |
| EP-0478918-A2 | Adducts of epoxy resins and active hydrogen containing compounds containing mesogenic moieties | THE DOW CHEMICAL COMPANY (US) | 1992-04-08 | — | — | EP | disclosed |
| EP-0469492-A2 | Polymer modified adducts of epoxy resins and active hydrogen containing compounds containing mesogenic moieties | THE DOW CHEMICAL COMPANY (US) | 1992-02-05 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180346500-A1 | ORGANIC/INORGANIC HYBRID NANOPARTICULATES MADE FROM IRON CARBOXYLATES | SLC39A3, SLC40A1, AOC3 | CYP3A4 1537/4885ACHE 2206/4885ALDH1A1 502/4885 |
| US-10738068-B2 | Organic/inorganic hybrid nanoparticulates made from iron carboxylates | SLC40A1, FECH, FTH1 | CYP3A4 1954/4885ACHE 2179/4885ALDH1A1 301/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.